TY - JOUR
T1 - NPHP1 (Nephrocystin-1) gene deletions cause adult-onset ESRD
AU - Snoek, Rozemarijn
AU - Van Setten, Jessica
AU - Keating, Brendan J.
AU - Israni, Ajay K.
AU - Jacobson, Pamala A.
AU - Oetting, William S.
AU - Matas, Arthur J.
AU - Mannon, Roslyn B.
AU - Zhang, Zhongyang
AU - Zhang, Weijia
AU - Hao, Ke
AU - Murphy, Barbara
AU - Reindl-Schwaighofer, Roman
AU - Heinzl, Andreas
AU - Oberbauer, Rainer
AU - Viklicky, Ondrej
AU - Conlon, Peter J.
AU - Stapleton, Caragh P.
AU - Bakker, Stephan J.L.
AU - Snieder, Harold
AU - Peters, Edith D.J.
AU - Van Der Zwaag, Bert
AU - Knoers, Nine V.A.M.
AU - De Borst, Martin H.
AU - Van Eerde, Albertien M.
N1 - Publisher Copyright:
Copyright © 2018 by the American Society of Nephrology.
PY - 2018/6
Y1 - 2018/6
N2 - Background Nephronophthisis (NPH) is the most prevalent genetic cause for ESRD in children. However, little is known about the prevalence of NPH in adult-onset ESRD. Homozygous full gene deletions of the NPHP1 gene encoding nephrocystin-1 are a prominent cause of NPH. We determined the prevalence of NPH in adults by assessing homozygous NPHP1 full gene deletions in adult-onset ESRD. Methods Adult renal transplant recipients from five cohorts of the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN) underwent single-nucleotide polymorphism genotyping. After quality control, we determined autosomal copy number variants (such as deletions) on the basis of median log2 ratios and B-allele frequency patterns. The findings were independently validated in one cohort. Patients were included in the analysis if they had adult-onset ESRD, defined as start of RRT at $18 years old. Results We included 5606 patients with adult-onset ESRD; 26 (0.5%) showed homozygous NPHP1 deletions. No donor controls showed homozygosity for this deletion. Median age at ESRD onset was 30 (range, 18–61) years old for patients with NPH, with 54% of patients age $30 years old. Notably, only three (12%) patients were phenotypically classified as having NPH, whereas most patients were defined as having CKD with unknown etiology (n=11; 42%). Conclusions Considering that other mutation types in NPHP1 or mutations in other NPH-causing genes were not analyzed, NPH is a relatively frequent monogenic cause of adult-onset ESRD. Because 88% of patients had not been clinically diagnosed with NPH, wider application of genetic testing in adult-onset ESRD may be warranted.
AB - Background Nephronophthisis (NPH) is the most prevalent genetic cause for ESRD in children. However, little is known about the prevalence of NPH in adult-onset ESRD. Homozygous full gene deletions of the NPHP1 gene encoding nephrocystin-1 are a prominent cause of NPH. We determined the prevalence of NPH in adults by assessing homozygous NPHP1 full gene deletions in adult-onset ESRD. Methods Adult renal transplant recipients from five cohorts of the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN) underwent single-nucleotide polymorphism genotyping. After quality control, we determined autosomal copy number variants (such as deletions) on the basis of median log2 ratios and B-allele frequency patterns. The findings were independently validated in one cohort. Patients were included in the analysis if they had adult-onset ESRD, defined as start of RRT at $18 years old. Results We included 5606 patients with adult-onset ESRD; 26 (0.5%) showed homozygous NPHP1 deletions. No donor controls showed homozygosity for this deletion. Median age at ESRD onset was 30 (range, 18–61) years old for patients with NPH, with 54% of patients age $30 years old. Notably, only three (12%) patients were phenotypically classified as having NPH, whereas most patients were defined as having CKD with unknown etiology (n=11; 42%). Conclusions Considering that other mutation types in NPHP1 or mutations in other NPH-causing genes were not analyzed, NPH is a relatively frequent monogenic cause of adult-onset ESRD. Because 88% of patients had not been clinically diagnosed with NPH, wider application of genetic testing in adult-onset ESRD may be warranted.
UR - http://www.scopus.com/inward/record.url?scp=85048016969&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048016969&partnerID=8YFLogxK
U2 - 10.1681/ASN.2017111200
DO - 10.1681/ASN.2017111200
M3 - Article
C2 - 29654215
AN - SCOPUS:85048016969
SN - 1046-6673
VL - 29
SP - 1772
EP - 1779
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 6
ER -